Mrs. Nicolle Theresa Sereday, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4271 Us Highway 12 E, White Sulphur Springs, MT 59645 Phone: 406-547-2316 Fax: 406-547-2162 |
News Archive
An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis. This new study was published online Feb. 16, 2010, and in the March edition of the Lancet Neurology.
Researchers from the UK recently reported the results of a sub-study that evaluates the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine when co-administered with an approved seasonal influenza vaccine.
A simple blood test capable of predicting if a person might develop Alzheimer's disease is within sight, and could eventually be used to help scientists reverse onset of the disease in those most at risk.
From a bacteria's perspective the environment is one big DNA waste yard. Researchers have now shown that bacteria can take up small as well as large pieces of old DNA from this scrapheap and include it in their own genome.
For several years, the pharmaceutical industry has tried to develop drugs that target a specific neurotransmitter receptor in the brain, the NMDA receptor. This receptor is present on almost every neuron in the human brain and is involved in learning and memory. NMDA receptors also have been implicated in several neurological and psychiatric conditions such as Alzheimer's disease, Parkinson's disease, schizophrenia and depression.
› Verified 6 days ago